AAO 2023: research demonstrates AI chatbots produce inaccurate responses to eye health queries
November 6th 2023In a study presented at the American Academy of Ophthalmology meeting, researchers asked practicing ophthalmologists to compare the ability of ChatGPT, Google Bard and Bing Chat in answering common patient questions
AAO 2023: OcuTerra provides update on Phase 2 DR:EAM diabetic retinopathy study
November 3rd 2023Kerrie Brady, president and chief executive officer of OcuTerra Therapeutics, shares progress in their Phase 2 DR:EAM Diabetic Retinopathy study, with promising results expected in Q1 2024 for their OTT166 eye drop treatment.